{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:18:10Z","timestamp":1779110290592,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572633"],"award-info":[{"award-number":["82572633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014761","name":"Natural Science Foundation of Qingdao Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0167"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0167"]}],"id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202510631009"],"award-info":[{"award-number":["202510631009"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117796","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:20:03Z","timestamp":1770769203000},"page":"117796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mutant NPM1-regulated estrogen signaling promotes leukemia cell survival by upregulating HGF and represents a therapeutic vulnerability"],"prefix":"10.1016","volume":"247","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinglu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-6034","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117796_b0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary management of acute myeloid leukemia: a review","volume":"10","author":"Venugopal","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bcp.2026.117796_b0010","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood.2019004226","article-title":"NPM1-mutated acute myeloid leukemia: from bench to bedside","volume":"136","author":"Falini","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.117796_b0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.117796_b0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41375-023-01882-4","article-title":"Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1","volume":"37","author":"Mill","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.117796_b0025","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1182\/blood-2005-05-2164","article-title":"Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations","volume":"106","author":"D\u00f6hner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.117796_b0030","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood-2005-08-3167","article-title":"Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)","volume":"107","author":"Thiede","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.117796_b0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","article-title":"The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017","volume":"13","author":"Yi","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.117796_b0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12938-025-01403-7","article-title":"Global, regional, and national burden of acute leukemia and its risk factors from 1990 to 2021 and predictions to 2040: findings from the global burden of disease study 2021","volume":"24","author":"Han","year":"2025","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.bcp.2026.117796_b0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1210\/er.2018-00087","article-title":"Estrogen receptors: new directions in the new millennium","volume":"39","author":"Hewitt","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2026.117796_b0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.20892\/j.issn.2095-3941.2024.0224","article-title":"Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review","volume":"21","author":"Gan","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bcp.2026.117796_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108350","article-title":"Anticancer or carcinogenic? The role of estrogen receptor \u03b2 in breast cancer progression","volume":"242","author":"Shen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117796_b0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13046-024-03160-2","article-title":"USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ER\u03b1","volume":"43","author":"Zhuang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117796_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170809","article-title":"The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression","volume":"134","author":"Lafront","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.117796_b0070","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7150\/ijbs.30930","article-title":"Estrogen receptor beta (ER\u03b2) mediated-CyclinD1 degradation via autophagy plays an anti-proliferation role in colon cells","volume":"15","author":"Wei","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117796_b0075","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0308319100","article-title":"Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D","volume":"101","author":"Str\u00f6m","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2026.117796_b0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.onc.1210712","article-title":"A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells","volume":"27","author":"Williams","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117796_b0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nature12932","article-title":"Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy","volume":"505","author":"Nakada","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.117796_b0090","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.7150\/ijbs.90483","article-title":"Genistin: a novel estrogen analogue targeting ER\u03b2 to alleviate thrombocytopenia","volume":"20","author":"Tang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117796_b0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/path.1883","article-title":"Differential expression of oestrogen receptors in human secondary lymphoid tissues","volume":"208","author":"Shim","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2026.117796_b0100","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2011.68","article-title":"Effect of ligand-activated estrogen receptor \u03b2 on lymphoma growth in vitro and in vivo","volume":"25","author":"Yakimchuk","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.117796_b0105","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1021\/acs.molpharmaceut.7b01151","article-title":"Diosmetin induces apoptosis of acute myeloid leukemia cells","volume":"15","author":"Roma","year":"2018","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.117796_b0110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41419-022-05357-9","article-title":"Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia","volume":"13","author":"Ren","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117796_b0115","article-title":"Mutant NPM1-regulated FTO-mediated m(6)A demethylation promotes leukemic cell survival via PDGFRB\/ERK signaling axis","volume":"12","author":"Xiao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.117796_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12964-025-02033-1","article-title":"Targeting HGF\/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion","volume":"23","author":"Xia","year":"2025","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.bcp.2026.117796_b0125","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1158\/0008-5472.CAN-23-3966","article-title":"Estrogen induces LCAT to maintain cholesterol homeostasis and suppress hepatocellular carcinoma development","volume":"84","author":"He","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117796_b0130","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.7150\/ijbs.100188","article-title":"NUSAP1 is upregulated by estrogen to promote lung adenocarcinoma growth and serves as a therapeutic target","volume":"20","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117796_b0135","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7150\/jca.100610","article-title":"Elucidating the role of estrogen effects in leukemia: insights from single-cell RNA sequencing and mendelian randomization","volume":"16","author":"Zhao","year":"2025","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2026.117796_b0140","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-06-2248","article-title":"Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype","volume":"106","author":"Schnittger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.117796_b0145","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/bloodadvances.2019001335","article-title":"The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting","volume":"4","author":"Juliusson","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcp.2026.117796_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41375-023-02068-8","article-title":"Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)","volume":"38","author":"Ozga","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.117796_b0155","first-page":"1115","article-title":"Recipient sex and donor leukemic cell characteristics determine leukemogenesis in patient-derived models","volume":"110","author":"Stanger","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2026.117796_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115494","article-title":"Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen","volume":"44","author":"Stomper","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.117796_b0165","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s12272-025-01583-9","article-title":"Advances and challenges of estrogen receptor-targeted agents in breast cancer","volume":"48","author":"Hu","year":"2025","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.bcp.2026.117796_b0170","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/febs.17270","article-title":"Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression","volume":"292","author":"Mangani","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2026.117796_b0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12964-019-0367-x","article-title":"Estrogen receptor \u03b1-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer","volume":"17","author":"Shen","year":"2019","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.bcp.2026.117796_b0180","first-page":"973","article-title":"The estrogen receptor CpG island is methylated in most hematopoietic neoplasms","volume":"56","author":"Issa","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117796_b0185","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1158\/1535-7163.MCT-17-0292","article-title":"Estrogen receptor \u03b2 is a novel target in acute myeloid leukemia","volume":"16","author":"Rota","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.117796_b0190","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/1471-2105-10-422","article-title":"Quantitative comparison of microarray experiments with published leukemia related gene expression signatures","volume":"10","author":"Klein","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bcp.2026.117796_b0195","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/bloodadvances.2024015132","article-title":"Estrogen receptor \u03b2 stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma","volume":"9","author":"\u00d6zistanbullu","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcp.2026.117796_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.554190","article-title":"BAG2-mediated inhibition of CHIP expression and overexpression of MDM2 contribute to the initiation of endometriosis by modulating estrogen receptor status","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.117796_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101014","article-title":"Cisplatin-activated ER\u03b2\/DCAF8 positive feedback loop induces chemoresistance in non-small cell lung cancer via PTEN\/Akt axis","volume":"71","author":"Hu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2026.117796_b0210","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41419-025-07870-z","article-title":"Elevated ER\u03b2 expression driven by low ASB8-mediated ubiquitination in lung adenocarcinoma promotes lymph node metastasis via tumor-associated neutrophils","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117796_b0215","article-title":"Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality","volume":"12","author":"Guo","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.bcp.2026.117796_b0220","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201903183RRR","article-title":"NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia","volume":"35","author":"Tang","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.117796_b0225","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-021-02122-2","article-title":"Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3","volume":"40","author":"Jing","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117796_b0230","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1073\/pnas.2002266117","article-title":"Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine","volume":"117","author":"Goodman","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.117796_b0235","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI113334","article-title":"Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure","volume":"81","author":"Gohda","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.117796_b0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0303-7207(94)90120-1","article-title":"Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary","volume":"104","author":"Liu","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117796_b0245","doi-asserted-by":"crossref","first-page":"E950","DOI":"10.1152\/ajpendo.00573.2014","article-title":"Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum","volume":"308","author":"Ono","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2026.117796_b0250","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41388-020-01393-x","article-title":"Autocrine HGF\/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia\/lymphoma","volume":"39","author":"Totani","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117796_b0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117796_b0260","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/ijms20020292","article-title":"Hepatocyte growth factor: a microenvironmental resource for leukemic cell growth","volume":"20","author":"Giannoni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117796_b0265","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.leu.2401080","article-title":"Hepatocyte growth factor\/scatter factor (HGF\/SF) affects proliferation and migration of myeloid leukemic cells","volume":"12","author":"Weimar","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.117796_b0270","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.2819","article-title":"Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia","volume":"18","author":"Kentsis","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.117796_b0275","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.leu.2402182","article-title":"Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome","volume":"15","author":"Verstovsek","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.117796_b0280","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/2643-3230.BCD-21-0055","article-title":"Inhibition of MET signaling with ficlatuzumab in combination with chemotherapy in refractory AML: clinical outcomes and high-dimensional analysis","volume":"2","author":"Wang","year":"2021","journal-title":"Blood Cancer Discovery"},{"key":"10.1016\/j.bcp.2026.117796_b0285","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.22.01994","article-title":"Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, recurrent\/metastatic head and neck cancer","volume":"41","author":"Bauman","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.117796_b0290","doi-asserted-by":"crossref","first-page":"12404","DOI":"10.3390\/ijms222212404","article-title":"Estrogen receptors as molecular targets of endocrine therapy for glioblastoma","volume":"22","author":"Gonz\u00e1lez-Mora","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117796_b0295","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/1078-0432.CCR-22-3949","article-title":"Autocrine 17-\u03b2-estradiol\/estrogen receptor-\u03b1 loop determines the response to immune checkpoint inhibitors in non-small cell lung cancer","volume":"29","author":"Anobile","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117796_b0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bjh.19519","article-title":"Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease","volume":"205","author":"Jen","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2026.117796_b0305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13046-024-03100-0","article-title":"Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia","volume":"43","author":"Ren","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117796_b0310","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/2159-8290.CD-24-1517","article-title":"Catalytic inhibition of KAT6\/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia","volume":"15","author":"Gordon","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.117796_b0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40170-025-00401-6","article-title":"NRF2 maintains redox balance via ME1 and NRF2 inhibitor synergizes with venetoclax in NPM1-mutated acute myeloid leukemia","volume":"13","author":"Hu","year":"2025","journal-title":"Cancer Metab."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:04:10Z","timestamp":1779109450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"alternative-id":["S0006295226001279"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117796","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutant NPM1-regulated estrogen signaling promotes leukemia cell survival by upregulating HGF and represents a therapeutic vulnerability","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117796"}}